Skip to main content

Vietnam Bans Import Of Glyphosate-Based U.S. Herbicides

Vietnam Bans Import Of Glyphosate-Based U.S. Herbicides

Vietnam Bans Import Of Glyphosate-Based U.S. Herbicides

Introduction

As the controversial Roundup bellwether trial was closely watched by nations all over the world, Vietnam imposed a ban on the import of glyphosate-based herbicides, after a U.S. court recently ruled that the weed killer played a substantial role in a California man's cancer.

This is the second time Monsanto was found liable for failing to warn about cancer risks of its Roundup products. One of Vietnam's daily newspaper head stated that they issued a document to ban new herbicide imports containing glyphosate, as soon as the recent Roundup verdict was out. The country aims to remove the substance from the list of usable herbicides in Vietnam in the near future. Vietnam's Plant Protection Department instructed businesses to stop approving new import contracts for glyphosate-containing herbicides; however, circulation in the country has not been affected by the decision.

The department also asked business owners and individuals to report back on the production, sales, and storage of these herbicides. Reports indicate the country uses nearly 30,000 tons of the chemical every year.

Currently, Bayer, the Roundup manufacturer faces over 9,300 Roundup lawsuits across the United States. All the lawsuits allege the company's product of causing non-Hodgkin's lymphoma in humans. All the Roundup lawsuits are consolidated into multidistrict litigation in the Northern District of California (MDL No. 2741; In Re: Roundup Products Liability Litigation).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!